Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × tazemetostat × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Follicular 2 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Rituximab 14 CT-P10 6 ibrutinib 5 Magnetic Resonance Spectroscopy 5 Cyclophosphamide 5 zanubrutinib 4 venetoclax 4 pirtobrutinib 4 glofitamab 4 fludarabine 4 Lenalidomide 4 Specimen Handling 3 obinutuzumab 2 fludarabine phosphate 2 acalabrutinib 2 Whole-Body Irradiation 2 Stem Cell Transplantation 2 Cytarabine 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1 tislelizumab 1 palbociclib 1 ixazomib 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Watchful Waiting 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡